Barbara Uhl
Medical University of Graz
12 Papers
30 Citations
Barbara Uhl is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Medicine & Cytarabine. The author has an hindex of 5, co-authored 12 publications. Previous affiliations of Barbara Uhl include University of Graz.
Chat about Author
Papers
Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease.
Walter Spindelboeck,Eduard Schulz,Barbara Uhl,Karl Kashofer,Ariane Aigelsreiter,Wilma Zinke-Cerwenka,Adnan Mulabecirovic,Patrizia Kump,Bettina Halwachs,Gregor Gorkiewicz,Heinz Sill,Hildegard T. Greinix,Christoph Högenauer,Peter Neumeister +13 more
TL;DR: Although aGvHD of any target organ represents morbidity, lower gastrointestinal (GI) tract involvement is complicated by high mortality.[2][2] Here, here,
123
Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.
Johannes Lorenz Berg,Bianca Perfler,Stefan Hatzl,Marie-Christina Mayer,Sonja Wurm,Barbara Uhl,Andreas Reinisch,Ingeborg Klymiuk,Sascha Tierling,Gudrun Pregartner,Gerhard Bachmaier,Andrea Berghold,Klaus Geissler,Martin Pichler,Martin Pichler,Gerald Hoefler,Herbert Strobl,Albert Wölfler,Heinz Sill,Armin Zebisch +19 more
TL;DR: In this article, the role of miRs in HMA efficacy in chronic myelomonocytic leukemia (CMML) was investigated and miR-125a downregulation was shown to be caused by hypermethylation of its upstream region and can be reversed by HMA treatment.
The CXCR4-CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro.
Katrin Pansy,Julia Feichtinger,Barbara Ehall,Barbara Uhl,Miriam Sedej,David Roula,Beata Pursche,Axel Wolf,Manuel Zoidl,Elisabeth Steinbauer,Verena Gruber,Hildegard Greinix,Katharina T. Prochazka,Gerhard G. Thallinger,Akos Heinemann,Christine Beham-Schmid,Peter Neumeister,Tanja M. Wrodnigg,Karoline Fechter,Alexander Josef Deutsch +19 more
TL;DR: The data indicate that the CXCR4-CXCL12-axis impacts the pathogenesis of DLBCL and represents a potential therapeutic target in aggressive lymphomas.
15
Imatinib stimulates prostaglandin E2 and attenuates cytokine release via EP4 receptor activation.
Thomas Bärnthaler,Katharina Jandl,Heinz Sill,Barbara Uhl,Yannick Schreiber,Magdalena Grill,Dominique Thomas,Rudolf Schicho,Gunther Marsche,Saša Frank,Akos Heinemann,Rufina Schuligoi +11 more
TL;DR: Imatinib increases PGE2 levels which leads to an EP4-dependent reduction in cytokine release and can also be observed in imatinib-treated patients at therapeutic doses, highlighting its potential as an anti-inflammatory agent.
13
Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration.
Veronica Caraffini,Bianca Perfler,Johannes Lorenz Berg,Barbara Uhl,Silvia Schauer,Karl Kashofer,Nassim Ghaffari-Tabrizi-Wizsy,Herbert Strobl,Albert Wölfler,Gerald Hoefler,Heinz Sill,Armin Zebisch +11 more
12